ASPG and cancer: The current commercial supply of L-asparaginase is chiefly derived from E. coli and Erwinia chrysanthemi but the drug from these sources are strongly immunogenic hence neutralizing the therapeutic effects and causing symptoms in more than 50% of cancer cases [6].